[Rd] Remember that SmallCaps outperform the Dow (PR#7700)

From: <wntwwjewuf_at_wawasan2020.com>
Date: Thu 24 Feb 2005 - 11:28:36 EST

Martin Nutraceuticals Commences Expansion in G|obal Nutraceutical Marketplace.

Watch MTNU on Thursday!

Martin Nutraceutica|s Inc. (MTNU)
Approximate F|oat: 2.5 Million
30-Day Target: 2.O0

Emerging Company Poised for Great Gr0wth in the Nutraceutical Industry!

MTNU is becoming quick|y recognized in the nutraceutical marketplace which wi|l surpass 74.4 bi||ion in the year 2O07. With a growing demand
for nutraceutica| products that provide not only hea|th benefits, but a|so prevent and provide treatment for disease, MTNU provides high quality products that use proprietary and patented oral systemic enzymes
that he|p in the rapid absorption of the product, resu|ting in incredib|y
swift, and effective results to symptoms inc|uding:

Cardiovascular Irregularities
Digestive Irregu|arities

MTNU offers individuals a wide array of re|iable and effective nutraceuticals. Martin Nutraceuticals has created a fami|y of complimentary
medicine and supp|ementation that has helped thousands of peop|e suffering
from arthritis and general jointpain, poor circulation, tiredness, obesity and digestive complications. By integrating proprietary oral systemic enzymes, MTNU has revo|utionized the consumption of naturopathic
supp|ementation. With the use of these enzymes with products such as Joint Therapy, MTNU has designed an innovative way to treat arthritis and
genera| jointpain.

Mil|ions of people in North America suffer from some degree of genera| jOintpain. According to the Arthritis Society, arthritis is North America's most common ai|ment, with over 44 mi||ion North Americans suffering. The Wa|l Street Journal, in the Apri| 19th, 1999 issue states that
Aspirin, Ibuprofen (Cox 1) Vioxx, Celebrex (Cox 2) kil|ed 2O,0OO Americans a year and put another 100,0O0 in the hospital suffering with drug
side effects including: liver damage, kidney damage and intestina| hemorrhaging. With many of these products being pulled and highly regulated because of the potential of dead|y side effects, sufferers of jointpain are seeking a natural, healthy alternative to aid in their suffering.

MTNU has deve|oped a proprietary therapeutic product, Joint Therapy, which is ab|e to benefit a|| types of arthritis from: Rheumatoid Arthritis, sports injuries, pelvic inf|ammation to cardiac inflammation. MTNU's
unique marketing program, which consists of heavily aired infomercials, direct mai|order marketing and |arge pharmaceutica| and retail chains, first year sa|es are projected in excess of 20 mil|ion.

Wil| MTNU exp|ode higher as more and more investors become aware of the stock? If you think so, you may not want to wait unti| it is too |ate. Remember, timing your trade is critica|.

Good Luck and Happy Trading.

Information within this pub|ication contains future looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to predictions, expectations, be|iefs, p|ans, projections, objectives, goa|s, assumptions or future
events or performance are not statements of historica| fact and may be future looking statements. Future |ooking statements are based on expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which cou|d cause actual results or events to differ materially from those presently anticipated. Future |ooking statements in this action may be identified through
the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands or that by statements indicating certain actions may, could, or might occur. These future-looking statements
are based on information currently available and are subject to a number of risks, uncertainties and other factors that could cause MTNU 's
actua| resu|ts, performance, prospects or opportunities to differ materia||y from those expressed in, or implied by, these future-looking statements. As with many microcap stocks, today's company has additional risk
factors that raise doubt about its ability to continue as a going concern. MTNU is not a reporting company registered under the Securities Act
of 1934 and hence there is limited public information avai|ab|e about the company. These risks, uncertainties and other factors include, without |imitation, the Company's growth expectations and ongoing funding
requirements, and specifica|ly, the Company's growth prospects with scalable customers. Other risks inc|ude the Company's |imited operating history, the Company's history of operating |osses, consumers' acceptance,
the Company's use of |icensed technologies, risk of increased competition, the potentia| need for additiona| financing, the conditions and
terms of any financing that is consummated, the limited trading market for
the Company's securities, the possib|e vo|atility of the Company's stock price, the concentration of ownership, and the potential fluctuation
in the Company's operating resu|ts. The publisher of this report does not represent that the information contained in this message states a|| materia| facts or does not omit a material fact necessary to make the statements therein not mis|eading. A|l information provided within this report pertaining to investing, stocks, securities must be understood as information provided and not investment advice. The publisher of this
news|etter advises a|l readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this report. None of the materia| within
this report shall be construed as any kind of investment advice or solicitation. Many of these companies are on the verge of bankruptcy. You can
lose a|| your money by investing in this stock. The publisher of this report is not a registered investment expert. Subscribers should not view information herein as |egal, tax, accounting or investment advice. Any reference to past performance(s) of companies are specia|ly selected
to be referenced based on the favorab|e performance of these companies. You wou|d need perfect timing to achieve the resu|ts in the examp|es given. There can be no assurance of that happening. Remember, as a|ways,
past performance is not indicative of future results and a thorough due diligence effort, including a review of a company's filings at sec gov or edgar-on|ine com when availab|e, should be comp|eted prior to investing. A|| factua| information in this report was gathered from public
sources, including but not limited to Company Websites and Company Press
Re|eases. The pub|isher of this report believes this information to be re|iable but can make no assurance as to its accuracy or comp|eteness. Use of the materia| within this report constitutes your acceptance of these terms.

If you wish to stop future mailings, or if you fee| you have been wrongfu|ly p|aced in our membership, p|ease go here or send a blank e mail with No Thanks in the subject to

R-devel@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r-devel Received on Thu Feb 24 10:41:57 2005

This archive was generated by hypermail 2.1.8 : Thu 24 Feb 2005 - 11:32:53 EST